These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25713290

  • 21. Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis.
    Ellis JM, Li LO, Wu PC, Koves TR, Ilkayeva O, Stevens RD, Watkins SM, Muoio DM, Coleman RA.
    Cell Metab; 2010 Jul 07; 12(1):53-64. PubMed ID: 20620995
    [Abstract] [Full Text] [Related]

  • 22. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.
    Young PA, Senkal CE, Suchanek AL, Grevengoed TJ, Lin DD, Zhao L, Crunk AE, Klett EL, Füllekrug J, Obeid LM, Coleman RA.
    J Biol Chem; 2018 Oct 26; 293(43):16724-16740. PubMed ID: 30190326
    [Abstract] [Full Text] [Related]

  • 23. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation.
    Sipula IJ, Brown NF, Perdomo G.
    Metabolism; 2006 Dec 26; 55(12):1637-44. PubMed ID: 17142137
    [Abstract] [Full Text] [Related]

  • 24. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.
    Gélinas R, Labarthe F, Bouchard B, Mc Duff J, Charron G, Young ME, Des Rosiers C.
    Am J Physiol Heart Circ Physiol; 2008 Apr 26; 294(4):H1571-80. PubMed ID: 18223187
    [Abstract] [Full Text] [Related]

  • 25. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
    Witham W, Yester K, O'Donnell CP, McGaffin KR.
    J Mol Cell Cardiol; 2012 Jul 26; 53(1):91-100. PubMed ID: 22507542
    [Abstract] [Full Text] [Related]

  • 26. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism.
    Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP.
    Cell Cycle; 2008 Aug 15; 7(16):2509-18. PubMed ID: 18719368
    [Abstract] [Full Text] [Related]

  • 27. Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.
    Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP.
    Am J Physiol Heart Circ Physiol; 2008 Aug 15; 295(2):H657-66. PubMed ID: 18552160
    [Abstract] [Full Text] [Related]

  • 28. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):270-5. PubMed ID: 24462768
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
    Parkes HA, Preston E, Wilks D, Ballesteros M, Carpenter L, Wood L, Kraegen EW, Furler SM, Cooney GJ.
    Am J Physiol Endocrinol Metab; 2006 Oct 07; 291(4):E737-44. PubMed ID: 16705061
    [Abstract] [Full Text] [Related]

  • 30. Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.
    Kundu BK, Zhong M, Sen S, Davogustto G, Keller SR, Taegtmeyer H.
    Cardiology; 2015 Oct 07; 130(4):211-20. PubMed ID: 25791172
    [Abstract] [Full Text] [Related]

  • 31. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD.
    Circ Res; 2004 May 14; 94(9):e78-84. PubMed ID: 15105298
    [Abstract] [Full Text] [Related]

  • 32. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.
    Sack MN, Harrington LS, Jonassen AK, Mjøs OD, Yellon DM.
    Cardiovasc Drugs Ther; 2000 Feb 14; 14(1):31-9. PubMed ID: 10755198
    [Abstract] [Full Text] [Related]

  • 33. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D, Datta Chaudhuri R, Niyogi S, Roy Chowdhuri S, Poddar Sarkar M, Chatterjee R, Chakrabarti P, Sarkar S.
    J Mol Cell Cardiol; 2020 Feb 14; 139():148-163. PubMed ID: 31958467
    [Abstract] [Full Text] [Related]

  • 34. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.
    Moellmann J, Mann PA, Kappel BA, Kahles F, Klinkhammer BM, Boor P, Kramann R, Ghesquiere B, Lebherz C, Marx N, Lehrke M.
    Diabetes Obes Metab; 2022 Nov 14; 24(11):2263-2272. PubMed ID: 35801343
    [Abstract] [Full Text] [Related]

  • 35. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
    Tian W, Wang D, Wang Z, Jiang K, Li Z, Tian Y, Kang X, Liu X, Li H.
    Gene; 2021 Jan 05; 764():145094. PubMed ID: 32860898
    [Abstract] [Full Text] [Related]

  • 36. Robust suppression of cardiac energy catabolism with marked accumulation of energy substrates during lipopolysaccharide-induced cardiac dysfunction in mice.
    Umbarawan Y, Syamsunarno MRAA, Obinata H, Yamaguchi A, Sunaga H, Matsui H, Hishiki T, Matsuura T, Koitabashi N, Obokata M, Hanaoka H, Haque A, Kunimoto F, Tsushima Y, Suematsu M, Kurabayashi M, Iso T.
    Metabolism; 2017 Dec 05; 77():47-57. PubMed ID: 28941596
    [Abstract] [Full Text] [Related]

  • 37. TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation.
    Huh JY, Reilly SM, Abu-Odeh M, Murphy AN, Mahata SK, Zhang J, Cho Y, Seo JB, Hung CW, Green CR, Metallo CM, Saltiel AR.
    Cell Metab; 2020 Dec 01; 32(6):1012-1027.e7. PubMed ID: 33152322
    [Abstract] [Full Text] [Related]

  • 38. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
    Bu SY, Mashek DG.
    J Lipid Res; 2010 Nov 01; 51(11):3270-80. PubMed ID: 20798351
    [Abstract] [Full Text] [Related]

  • 39. Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation.
    Ma Y, Zha J, Yang X, Li Q, Zhang Q, Yin A, Beharry Z, Huang H, Huang J, Bartlett M, Ye K, Yin H, Cai H.
    Oncogene; 2021 Mar 01; 40(10):1806-1820. PubMed ID: 33564069
    [Abstract] [Full Text] [Related]

  • 40. Effects of hormone-sensitive lipase disruption on cardiac energy metabolism in response to fasting and refeeding.
    Suzuki J, Ueno M, Uno M, Hirose Y, Zenimaru Y, Takahashi S, Osuga J, Ishibashi S, Takahashi M, Hirose M, Yamada M, Kraemer FB, Miyamori I.
    Am J Physiol Endocrinol Metab; 2009 Nov 01; 297(5):E1115-24. PubMed ID: 19706782
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.